Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87651-87700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06802588
Optimization of the Management of Non-Traumatic Intracerebral Hemorrhage (OPT-ICH)
N/ARecruiting
600 participants
Started: May 1, 2022 · Completed: May 1, 2027
1 condition1 sponsor1 location
NCT06095869
Progressive Relaxation Exercises,Breastfeeding
NARecruiting
114 participants
Started: May 1, 2022 · Completed: Nov 30, 2023
1 condition1 sponsor1 location
NCT05356520
Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction
NARecruiting
212 participants
Started: May 1, 2022 · Completed: May 31, 2028
1 condition6 sponsors1 location
NCT06800599
Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment
N/AEnrolling by invitation
7,000 participants
Started: May 1, 2022 · Completed: Dec 31, 2037
1 condition1 sponsor1 location
NCT05664451
WI-INTUIT: Bridging Community Based Continence Promotion and Primary Care
NAActive, not recruiting
40 participants
Started: May 1, 2022 · Completed: Apr 30, 2026
1 condition3 sponsors3 locations
NCT05316480
Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms
PHASE2Not yet recruiting
42 participants
Started: May 1, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT04484727
"Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs"
N/ARecruiting
200 participants
Started: May 1, 2022 · Completed: Dec 31, 2026
5 conditions2 sponsors1 location
NCT05332990
Multicenter Comparison of Interictal HFO as a Predictor of Seizure Freedom
N/AEnrolling by invitation
300 participants
Started: May 1, 2022 · Completed: May 1, 2024
1 condition10 sponsors1 location
NCT05332067
Omalizumab Before Onset of Exacerbations
PHASE2Recruiting
300 participants
Started: May 1, 2022 · Completed: Mar 1, 2028
3 conditions2 sponsors1 location
NCT05339737
The Nociception Level (NOL) Index for Pain Assessment in the Adult Intensive Care Unit
N/ANot yet recruiting
411 participants
Started: May 1, 2022 · Completed: Mar 31, 2026
4 conditions3 sponsors0 locations
NCT05354102
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
PHASE1Active, not recruiting
11 participants
Started: May 1, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT05348837
Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease
N/ARecruiting
15 participants
Started: May 1, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05055648
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
PHASE3Recruiting
396 participants
Started: May 1, 2022 · Completed: Dec 1, 2032
4 conditions19 sponsors15 locations
NCT05037461
Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients
NARecruiting
20 participants
Started: May 1, 2022 · Completed: Dec 1, 2026
2 conditions6 sponsors1 location
NCT04970446
Microbial Restoration in Inflammatory Bowel Diseases
PHASE1/PHASE2Recruiting
120 participants
Started: May 1, 2022 · Completed: Apr 1, 2026
4 conditions5 sponsors1 location
NCT05731336
A Prospective Cohort Study of Advanced Colorectal Cancer Treated With Oxaliplatin and Irinotecan.
N/ARecruiting
500 participants
Started: May 1, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04404985
Endovascular vs Surgical Arteriovenous Fistula Outcomes
NAActive, not recruiting
21 participants
Started: May 1, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05359185
Empowering Families Project
NAActive, not recruiting
666 participants
Started: May 1, 2022 · Completed: Apr 30, 2025
3 conditions2 sponsors1 location
NCT04614870
DETEC® Esterase for Screening Wound Infection at Point of Care
N/ARecruiting
200 participants
Started: May 1, 2022 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT06154044
Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support
PHASE2Recruiting
10 participants
Started: May 1, 2022 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT05713006
Alectinib Pharmacokinetic in Patients With NSCLC
PHASE1/PHASE2Recruiting
45 participants
Started: May 1, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05269992
Childrens Real Food Tolerance Study
NARecruiting
60 participants
Started: May 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05562531
Botulinum Toxin Administration on Masticatory Performance
N/ARecruiting
30 participants
Started: May 1, 2022 · Completed: Dec 1, 2023
2 conditions1 sponsor1 location
NCT05916898
The Lower Silesia Shockwave Registry
N/ARecruiting
400 participants
Started: May 1, 2022 · Completed: May 1, 2027
2 conditions2 sponsors2 locations
NCT05351268
3DPCT Combined With CT Guided RISI in the Treatment of Thoracic Malignant Tumors
NARecruiting
30 participants
Started: May 1, 2022 · Completed: Apr 30, 2026
4 conditions1 sponsor1 location
NCT05775614
UROtainer for Bladder Catheter Maintenance, Infection Prevention and Quality of Life
NAEnrolling by invitation
70 participants
Started: May 1, 2022 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT05352022
Lowering Food Insecurity and Improving Diabetes With Financial Incentives
NAActive, not recruiting
150 participants
Started: May 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05433467
CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection
NARecruiting
5 participants
Started: May 1, 2022 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT05218694
Coronary Computed Tomography Angiography For Optimized Invasive Coronary examInation
NARecruiting
120 participants
Started: May 1, 2022 · Completed: Sep 1, 2024
2 conditions1 sponsor1 location
NCT06838130
AI-Enhanced Analysis of Breast Density and Background Parenchymal Enhancement (BPE)
N/AEnrolling by invitation
213 participants
Started: May 1, 2022 · Completed: Feb 28, 2025
2 conditions2 sponsors1 location
NCT05268042
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
NARecruiting
80 participants
Started: May 1, 2022 · Completed: May 1, 2026
2 conditions2 sponsors1 location
NCT06094166
Quantitative MR Parameters in Non-myelopathic Degenerative Cervical Spinal Cord Compression: a Longitudinal Study.
N/ARecruiting
160 participants
Started: May 1, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05316467
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
PHASE2/PHASE3Recruiting
89 participants
Started: May 1, 2022 · Completed: Feb 28, 2027
4 conditions1 sponsor1 location
NCT05715502
Focal Salvage Brachytherapy Study (FocaSaBra)
NARecruiting
100 participants
Started: May 1, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05702281
Evaluation of the Safety and Efficacy of the ReLARC Inserter During the Insertion Procedure of GYNEFIX Intrauterine Copper Bearing Contraceptive Device with a Follow-up of 3 Years.
NARecruiting
120 participants
Started: May 1, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05237999
Effectiveness of a Blended Care Parenting Intervention for Parents With PTSD (KopOpOuders-PTSD)
NARecruiting
142 participants
Started: May 1, 2022 · Completed: Dec 31, 2024
1 condition5 sponsors1 location
NCT05517655
BEGIN Novel ImagiNG Biomarkers
PHASE4Recruiting
44 participants
Started: May 1, 2022 · Completed: Nov 1, 2028
1 condition4 sponsors3 locations
NCT05431101
abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release
NARecruiting
2,604 participants
Started: May 1, 2022 · Completed: Apr 1, 2028
3 conditions2 sponsors2 locations
NCT05359796
Clinical Characteristics of People With Long-term Type 1 Diabetes
N/ARecruiting
400 participants
Started: May 1, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05420246
Efficacy and Safety of Ainuovirine Treating With AIDS Patients
N/ARecruiting
450 participants
Started: May 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05340231
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
PHASE2Not yet recruiting
100 participants
Started: May 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05343507
Ketamine to Treat Patients With Post-comatose Disorders of Consciousness
PHASE2/PHASE3Recruiting
30 participants
Started: May 1, 2022 · Completed: May 1, 2026
1 condition3 sponsors1 location
NCT05348694
OsteoPreP: Food Supplements for Postmenopausal Bone Health
PHASE4Active, not recruiting
160 participants
Started: May 1, 2022 · Completed: Apr 30, 2025
5 conditions3 sponsors1 location
NCT05345717
Novel Desensitization Kidney Transplantation
PHASE1/PHASE2Recruiting
5 participants
Started: May 1, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05449145
The Effects of Vitamin D Plus Omega-3 Polyunsaturated Fatty Acids in Patients With Episodic Migraine
NARecruiting
120 participants
Started: May 1, 2022 · Completed: Apr 15, 2024
1 condition1 sponsor1 location
NCT05520632
Autism Spectrum Disorder: BAEPs Findings and Behavioral Responses to Sounds
N/ARecruiting
120 participants
Started: May 1, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT04298437
Addressing Depression and Positive Parenting Techniques (ADAPT)
NARecruiting
80 participants
Started: May 1, 2022 · Completed: Dec 1, 2024
7 conditions2 sponsors2 locations
NCT05644314
Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis
NARecruiting
144 participants
Started: May 1, 2022 · Completed: May 31, 2029
2 conditions1 sponsor1 location
NCT06273150
Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study
N/ARecruiting
225 participants
Started: May 1, 2022 · Completed: Apr 30, 2026
1 condition3 sponsors3 locations
NCT06591351
Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA
PHASE3Recruiting
870 participants
Started: May 1, 2022 · Completed: Oct 10, 2024
1 condition1 sponsor1 location